tirzepatide 12.5 mg Injection 12.5mg Injection at ₹ 27499/vial | Tirzepatide Injection in Nagpur Mounjaro (tirzepatide): Uses, Side Effects,

According to the Wegovy Summary of Product Characteristics (SmPC), the medication is approved for use in three specific subcutaneous injection sites: the abdomen (stomach area), the thigh (front of the upper leg), and the upper arm

They help normalize insulin and glucose balance, and reduce the amount of glucose that's being produced by your liver when it's not needed

Participants remained in-house at the clinical study site until 8496 h after each administration of study product

References Beard, T., Leslie, J., & Nemeth, J

Approved in December 2025, it is uniquely positioned as an oral alternative without compromising effectiveness for patients in Warrenton aiming for weight management

Tirzepatide: A dual-agonist that targets two pathways (GLP-1 and GIP)